Red Flags Detected
- Delisting (new) — Company faces imminent Nasdaq delisting unless it successfully appeals by May 29, 2026, with trading suspension starting June 2.
DNA X faces Nasdaq delisting by June 2 as it raises $3M via convertible note secured by subsidiary
Filed May 27, 2026 · Period ending May 20, 2026 · ~1 min read
5 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade SONM commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
View original filing on SEC.gov
Generated by AI · May 27, 2026 9:05 PM